Table 2.
Analysis of association between thromboembolism occurrence and different diagnoses of hematological malignancies.
| VTE | ATE | |||
|---|---|---|---|---|
| Frequency | p-Value | Frequency | p-Value | |
| All | 54 of 1283 4.21% |
- | 47 of 1283 3.66% |
- |
| AML | 17 of 270 6.30% |
0.055 | 8 of 270 2.96% |
0.491 |
| NHL | 7 of 250 2.80% |
0.216 | 6 of 250 2.40% |
0.236 |
| MM | 10 of 223 4.48% |
0.822 | 11 of 223 4.93% |
0.267 |
| CLL | 3 of 101 2.97% |
0.698 * | 6 of 101 5.94% |
0.204 |
| ALL | 7 of 76 9.21% |
0.025 | 2 of 76 2.63% |
0.858 * |
| MDS | 1 of 70 1.43% |
0.376 * | 3 of 70 4.29% |
0.966 * |
| HL | 0 of 56 0% |
0.206 * | 1 of 56 1.79% |
0.688 * |
| CML | 0 of 51 0% |
0.241 * | 4 of 51 7.84% |
0.215 * |
| Chronic myeloproliferative disease | 7 of 48 14.58% |
0.0003 | 4 of 48 8.33% |
0.173 * |
* Yates corrected chi-square.